JP Stock MarketDetailed Quotes

190A Chordia Therapeutics

Watchlist

249
+26+11.66%

20min DelayMarket Closed Nov 22 15:30 JST

16.91BMarket Cap-7899P/E (Static)

Chordia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Aug 31, 2022

(FY)Aug 31, 2021

Total revenue

800M

Cost of revenue

Gross profit

Operating expense

22.97%1.83B

1.49B

Selling and administrative expenses

9.66%188M

--171.44M

-Selling and marketing expense

9.66%188M

--171.44M

Research and development costs

25.18%1.66B

--1.32B

Total other operating income

119.45%14.56M

--6.64M

Operating profit

-166.02%-1.83B

-687.76M

Net non-operating interest income (expenses)

Net investment income

-729.58%-2.58M

-311K

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

Special income (charges)

Other non-operating income (expenses)

-65.93%55.49M

162.86M

Income before tax

-238.27%-1.78B

-525.21M

Income tax

27.37%2.42M

1.9M

Net income

-237.51%-1.78B

-527.11M

Net income continuous operations

-237.51%-1.78B

---527.11M

Noncontrolling interests

Net income attributable to the company

-237.51%-1.78B

-527.11M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-237.51%-1.78B

-527.11M

Gross dividend payment

Basic earnings per share

-237.51%-31.5191

-9.3386

Diluted earnings per share

-237.51%-31.5191

-9.3386

Dividend per share

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(FY)Aug 31, 2022	(FY)Aug 31, 2021
Total revenue	0	800M
Cost of revenue
Gross profit
Operating expense	22.97%1.83B	1.49B
Selling and administrative expenses	9.66%188M	--171.44M
-Selling and marketing expense	9.66%188M	--171.44M
Research and development costs	25.18%1.66B	--1.32B
Total other operating income	119.45%14.56M	--6.64M
Operating profit	-166.02%-1.83B	-687.76M
Net non-operating interest income (expenses)
Net investment income	-729.58%-2.58M	-311K
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses)	-65.93%55.49M	162.86M
Income before tax	-238.27%-1.78B	-525.21M
Income tax	27.37%2.42M	1.9M
Net income	-237.51%-1.78B	-527.11M
Net income continuous operations	-237.51%-1.78B	---527.11M
Noncontrolling interests
Net income attributable to the company	-237.51%-1.78B	-527.11M
Preferred stock dividends
Other under preferred stock dividend	0	0
Net income attributable to common stockholders	-237.51%-1.78B	-527.11M
Gross dividend payment
Basic earnings per share	-237.51%-31.5191	-9.3386
Diluted earnings per share	-237.51%-31.5191	-9.3386
Dividend per share
Currency Unit	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data